1MRKX:BIT
Merck & Co Inc
128,18 €
arrow_downward
-0,59%(-0,76) 1D
2 okt, 17:26:00 GMT+2 · EUR
search
Bütün simvollar
| Simvol | Qiymət | Dəyişiklik | % Dəyişiklik |
|---|
Xəbər materialları
Veb mənbələri və xəbər partnyorlarından
MarketBeat
·
1 saat öncə
48,205 Merck & Co., Inc. $MRK Shares Sold by Courier Capital LLC
Yahoo Finance
·
6 saat öncə
Merck (MRK) Reports a Negative Operating Margin and Pays Out 266% of Earnings. What Explains Both?
TipRanks
·
7 saat öncə
Merck appoints Paul Diaz to its board of directors
The Pharma Letter
·
9 saat öncə
Nimbus hires Merck & Co dealmaker as chief business officer
Profil
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000.
In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia